Enveric Biosciences, Inc. (ENVB)
1.42
-0.04
(-2.74%)
USD |
NASDAQ |
Sep 11, 16:00
1.445
+0.02
(+1.76%)
After-Hours: 20:00
Enveric Biosciences Price to Book Value : 0.6915 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.6915 |
| September 10, 2026 | 0.711 |
| September 09, 2026 | 0.7085 |
| September 08, 2026 | 0.6915 |
| September 04, 2026 | 0.6769 |
| September 03, 2026 | 0.7012 |
| September 02, 2026 | 0.7012 |
| September 01, 2026 | 0.6671 |
| August 31, 2026 | 0.6671 |
| August 28, 2026 | 0.6671 |
| August 27, 2026 | 0.6671 |
| August 26, 2026 | 0.6671 |
| August 25, 2026 | 0.711 |
| August 24, 2026 | 0.6866 |
| August 21, 2026 | 0.6964 |
| August 20, 2026 | 0.6769 |
| August 19, 2026 | 0.6379 |
| August 18, 2026 | 0.6574 |
| August 17, 2026 | 0.7207 |
| August 14, 2026 | 0.7475 |
| August 13, 2026 | 0.7353 |
| August 12, 2026 | 0.7548 |
| August 11, 2026 | 0.7548 |
| August 10, 2026 | 0.7499 |
| August 07, 2026 | 0.7548 |
| Date | Value |
|---|---|
| August 06, 2026 | 0.7597 |
| August 05, 2026 | 0.8132 |
| August 04, 2026 | 0.823 |
| August 03, 2026 | 0.7791 |
| July 31, 2026 | 0.7645 |
| July 30, 2026 | 0.6964 |
| July 29, 2026 | 0.6477 |
| July 28, 2026 | 0.6477 |
| July 27, 2026 | 0.6525 |
| July 24, 2026 | 0.6282 |
| July 23, 2026 | 0.6428 |
| July 22, 2026 | 0.6525 |
| July 21, 2026 | 0.6428 |
| July 20, 2026 | 0.6184 |
| July 17, 2026 | 0.6525 |
| July 16, 2026 | 0.6623 |
| July 15, 2026 | 0.6428 |
| July 14, 2026 | 0.6428 |
| July 13, 2026 | 0.6379 |
| July 10, 2026 | 0.6574 |
| July 09, 2026 | 0.6964 |
| July 08, 2026 | 0.6915 |
| July 07, 2026 | 0.7061 |
| July 06, 2026 | 0.7207 |
| July 02, 2026 | 0.7061 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| LENZ Therapeutics, Inc. | 0.6476 |
| Impact BioMedical, Inc. | 4.609 |
| ANI Pharmaceuticals, Inc. | 2.700 |
| Corcept Therapeutics, Inc. | 17.25 |
| Veru, Inc. | 1.466 |
Price to Book Value Related Metrics
| Price | 1.42 |
| Earnings Yield | -1.16K% |
| Market Cap | 5.589M |